Use of Synvisc® in Knee Osteoarthritis - Survey on Practice

Completed

• Conditions: Osteoarthritis
• Interventions: Drug: Synvisc®

• Registration Number: NCT02195544
• Lead Sponsor: Boehringer Ingelheim

Brief Summary

Study of prescription methods in everyday medical practice, tolerance profile and effect of Synvisc® until six months of follow-up.

Detailed Description

Not available

Study Timeline

• Study Start: 1998-10
• Primary Completion: 2000-04
• Status Verified: 2014-07
• Study First Submitted: 2014-07-18
• Study First Submitted QC: 2014-07-18
• Last Update Submitted: 2014-07-18
• Study First Posted: 2014-07-21
• Last Update Posted: 2014-07-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• not applicable

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Synvisc®	Synvisc®	-

Primary Outcome Measures

Name	Time	Method
Amount of medication consumed	up to 6 months
Patient satisfaction on a 4-point verbal rating scale	up to 6 months
Change in clinical symptoms	up to 6 months	assessed via questionnaire

Secondary Outcome Measures

Name	Time	Method
Number of patients with adverse events	up to 6 months